Cargando...
Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
In a previous study, we determined that major pathologic response (MPR) as indicated by the percentage of residual viable tumor cells predicted overall survival (OS) in patients with non‐small‐cell lung cancer (NSCLC) who received neoadjuvant chemotherapy. In this study, we assessed whether two gene...
Gardado en:
| Publicado en: | Cancer Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6010873/ https://ncbi.nlm.nih.gov/pubmed/29673125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1505 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|